Comparative proteomic profiling in squamous cell carcinoma of the uterine cervix

Proteomics - Clinical Applications

Volumn 5, Issue 3-4, 2011, Pages 133-140

  Fukushima, Chikako ^a   Murakami, Akihiro ^a   Yoshitomi, Keiko ^a   Sueoka, Kotaro ^a   Nawata, Shugo ^a   Nakamura, Kazuyuki ^a   Sugino, Norihiro ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

HSP70; Squamous cell carcinoma; Transgelin 2; Uterine cervical cancer

Indexed keywords

BIOLOGICAL MARKER; CYTOKERATIN 19; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; TRANSGELIN; TRANSGELIN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 79953068988     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201000077     Document Type: Article

References (33)

1. World Health Organization, Comprehensive Cervical Cancer Control, 2006.
2. Munoz, N., Bosch, F. X., Castellsague, X., Diaz, M. et al., Against which human papillomavirus types shall we vaccinate and screen? Int. Perspect. Int. J. Cancer 2004, 111, 278-285.
3. de Bruijn, H. W., Duk, J. M., van der Zee, A. G., Pras, E. et al., The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix. Tumour Biol. 1998, 19, 505-516.
4. Gadducci, A., Tana, R., Fanucchi, A., Genazzani, A. R., Biochemical prognostic factors and risk of relapses in patients with cervical cancer. Gynecol. Oncol. 2007, 107, S23-S26.
5. Gaarenstroom, K. N., Kenter, G. G., Bonfrer, J. M., Korse, C. M. et al., Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? Gynecol. Oncol. 2000, 77, 164-170.
6. Patsner, B., Orr Jr J. W., Allmen, T., Does preoperative serum squamous cell carcinoma antigen level predict occult extracervical disease in patients with stage Ib invasive squamous cell carcinoma of the cervix? Obstet. Gynecol. 1989, 74, 786-788.
7. Lehman, M., Thomas, G., Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer? Int. J. Gynecol. Cancer 2001, 11, 87-99.
8. Long 3rd H. J., Bundy, B. N., Grendys Jr E. C., Benda, J. A. et al., Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J. Clin. Oncol. 2005, 23, 4626-4633.
9. Berek, J. S., Taylor, P. T., Nicodemus, C. F., CA125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer. J. Immunother. 2008, 31, 207-214.
10. Li, L. S., Kim, H., Rhee, H., Kim, S. H. et al., Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of nonsmall cell lung carcinoma. Proteomics 2004, 4, 3394-3400.
11. Qi, Y., Chiu, J. F., Wang, L., Kwong, D. L., He, Q. Y., Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 2005, 5, 2960-2971.
12. Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N. et al., Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics 2006, 6, 3894-3900.
13. Mikuriya, K., Kuramitsu, Y., Ryozawa, S., Fujimoto, M. et al., Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int. J. Oncol. 2007, 30, 849-855.
14. Yokoyama, Y., Kuramitsu, Y., Takashima, M., Iizuka, N. et al., Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 2004, 4, 2111-2116.
15. Yuan, X., Kuramitsu, Y., Furumoto, H., Zhang, X. et al., Nuclear protein profiling of Jurkat cells during heat stress-induced apoptosis by 2-DE and MS/MS. Electrophoresis 2007, 28, 2018-2026.
16. Murakami, A., Nakagawa, T., Kaneko, M., Nawata, S. et al., Suppression of SCC antigen promotes cancer cell invasion and migration through the decrease in E-cadherin expression. Int. J. Oncol. 2006, 29, 1231-1235.
17. Nakagawa, T., Murakami, A., Torii, M., Nawata, S. et al., E-cadherin increases squamous cell carcinoma antigen expression through phosphatidylinositol-3 kinase-Akt pathway in squamous cell carcinoma cell lines. Oncol. Rep. 2007, 18, 175-179.
18. Nawata, S., Suminami, Y., Hirakawa, H., Murakami, A. et al., Nondenaturing two-dimensional electrophoretic analysis of loop-sheet polymerization of serpin, squamous cell carcinoma antigen-2. Electrophoresis 2001, 22, 161-164.
19. Kuramitsu, Y., Nakamura, K., Proteomic analysis of cancer tissues: shedding light on carcinogenesis and possible biomarkers. Proteomics 2006, 6, 5650-5661.
20. Zhu, X., Lv, J., Yu, L., Wu, J. et al., Proteomic identification of differentially-expressed proteins in squamous cervical cancer. Gynecol. Oncol. 2008.
21. Schmitt, E., Gehrmann, M., Brunet, M., Multhoff, G., Garrido, C., Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J. Leukoc. Biol. 2007, 81, 15-27.
22. Chen, J., He, Q. Y., Yuen, A. P., Chiu, J. F., Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 2004, 4, 2465-2475.
23. Jazii, F. R., Najafi, Z., Malekzadeh, R., Conrads, T. P. et al., Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer. World J. Gastroenterol. 2006, 12, 7104-7112.
24. Ralhan, R., Kaur, J., Differential expression of Mr 70, 000 heat shock protein in normal, premalignant, and malignant human uterine cervix. Clin. Cancer Res. 1995, 1, 1217-1222.
25. Nanbu, K., Konishi, I., Mandai, M., Kuroda, H. et al., Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Cancer Detect. Prev. 1998, 22, 549-555.
26. Thanner, F., Sutterlin, M. W., Kapp, M., Rieger, L. et al., Heat-shock protein 70 as a prognostic marker in node-negative breast cancer. Anticancer Res. 2003, 23, 1057-1062.
27. Geisler, J. P., Tammela, J. E., Manahan, K. J., Geisler, H. E. et al., HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up. Eur. J. Gynaecol. Oncol. 2004, 25, 165-168.
28. Cornford, P. A., Dodson, A. R., Parsons, K. F., Desmond, A. D. et al., Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res. 2000, 60, 7099-7105.
29. Shapland, C., Hsuan, J. J., Totty, N. F., Lawson, D., Purification and properties of transgelin: a transformation and shape change sensitive actin-gelling protein. J. Cell. Biol. 1993, 121, 1065-1073.
30. Huang, Q., Chen, W., Wang, L., Lin, W. et al., Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology. J. Cancer Res. Clin. Oncol. 2008, 134, 1219-1227.
31. Klade, C. S., Voss, T., Krystek, E., Ahorn, H. et al., Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 2001, 1, 890-898.
32. Bae, S. M., Lee, C. H., Cho, Y. L., Nam, K. H. et al., Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol. Oncol. 2005, 99, 26-35.
33. Shields, J. M., Rogers-Graham, K., Der, C. J., Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways. J. Biol. Chem. 2002, 277, 9790-9799.